{
"info": {
"nct_id": "NCT06715020",
"official_title": "Establishment and Clinical Transformation of ADC Drug Efficacy Evaluation System for Breast Cancer Based on Molecular Imaging",
"inclusion_criteria": "1. Age 18-75 years old, male or female, ECOG score 0 or 1 points (see the table in Annex 2 for the score table);\n2. Blood routine and liver and kidney function meet the following criteria: Blood routine: WBC ≥ 4.0×109 L or neutrophil ≥1.5×109 /L, PLT ≥ 100×109/L, Hb≥ 90 g/L; PT or APTT ≤ 1.5 ULN; Liver and kidney function: T-Bil ≤ 1.5×ULT(upper limit of normal), ALT and AST≤ 2.5 ULN or ≤ 5×ULT(subjects with liver metastasis), ALP ≤ 2.5 ULN(ALP ≤ 4.5 ULN if there is bone metastasis or liver metastasis); BUN ≤ 1.5×ULT, SCr ≤ 1.5×ULT;\n3. Patients with confirmed or suspected breast cancer;\n4. Expected survival ≥12 weeks;\n5. Good follow-up compliance;\n6. Women of childbearing age (15 to 49 years old) must undergo a pregnancy test within 7 days before the start of the test and the result is negative; Fertile men and women must consent to the use of effective contraception to ensure pregnancy during the study period and within 3 months of the examination;\n7. Subject patients can fully understand and voluntarily participate in this experiment, and sign informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "1. Severe abnormal liver and kidney function;\n2. Pregnant, pregnant and lactating women;\n3. Can not lie flat for half an hour;\n4. Unable to obtain informed consent;\n5. Suffering from claustrophobia or other mental illness;\n6. People who are known to be allergic to the investigational drug or its excipients in the investigational therapy;\n7. Other conditions deemed unsuitable for participation in the trial by the investigator.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Age 18-75 years old, male or female, ECOG score 0 or 1 points (see the table in Annex 2 for the score table);",
"criterions": [
{
"exact_snippets": "Age 18-75 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "male or female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "allowed values",
"expected_value": [
"male",
"female"
]
}
]
},
{
"exact_snippets": "ECOG score 0 or 1 points",
"criterion": "ECOG score",
"requirements": [
{
"requirement_type": "allowed values",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "2. Blood routine and liver and kidney function meet the following criteria: Blood routine: WBC ≥ 4.0×109 L or neutrophil ≥1.5×109 /L, PLT ≥ 100×109/L, Hb≥ 90 g/L; PT or APTT ≤ 1.5 ULN; Liver and kidney function: T-Bil ≤ 1.5×ULT(upper limit of normal), ALT and AST≤ 2.5 ULN or ≤ 5×ULT(subjects with liver metastasis), ALP ≤ 2.5 ULN(ALP ≤ 4.5 ULN if there is bone metastasis or liver metastasis); BUN ≤ 1.5×ULT, SCr ≤ 1.5×ULT;",
"criterions": [
{
"exact_snippets": "Blood routine: WBC ≥ 4.0×109 L",
"criterion": "WBC",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 4.0,
"unit": "×10^9 L"
}
}
]
},
{
"exact_snippets": "Blood routine: ... neutrophil ≥1.5×109 /L",
"criterion": "neutrophil",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "×10^9 /L"
}
}
]
},
{
"exact_snippets": "Blood routine: ... PLT ≥ 100×109/L",
"criterion": "PLT",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "Blood routine: ... Hb≥ 90 g/L",
"criterion": "Hb",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 90,
"unit": "g/L"
}
}
]
},
{
"exact_snippets": "PT or APTT ≤ 1.5 ULN",
"criterion": "PT or APTT",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "ULN"
}
}
]
},
{
"exact_snippets": "Liver and kidney function: T-Bil ≤ 1.5×ULT(upper limit of normal)",
"criterion": "T-Bil",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "ULT"
}
}
]
},
{
"exact_snippets": "Liver and kidney function: ... ALT and AST≤ 2.5 ULN or ≤ 5×ULT(subjects with liver metastasis)",
"criterion": "ALT and AST",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2.5,
"unit": "ULN"
},
{
"operator": "<=",
"value": 5,
"unit": "ULT"
}
]
}
}
]
},
{
"exact_snippets": "Liver and kidney function: ... ALP ≤ 2.5 ULN(ALP ≤ 4.5 ULN if there is bone metastasis or liver metastasis)",
"criterion": "ALP",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2.5,
"unit": "ULN"
},
{
"operator": "<=",
"value": 4.5,
"unit": "ULN"
}
]
}
}
]
},
{
"exact_snippets": "Liver and kidney function: ... BUN ≤ 1.5×ULT",
"criterion": "BUN",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "ULT"
}
}
]
},
{
"exact_snippets": "Liver and kidney function: ... SCr ≤ 1.5×ULT",
"criterion": "SCr",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "ULT"
}
}
]
}
]
},
{
"line": "3. Patients with confirmed or suspected breast cancer;",
"criterions": [
{
"exact_snippets": "confirmed or suspected breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"confirmed",
"suspected"
]
}
]
}
]
},
{
"line": "4. Expected survival ≥12 weeks;",
"criterions": [
{
"exact_snippets": "Expected survival ≥12 weeks",
"criterion": "expected survival",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "5. Good follow-up compliance;",
"criterions": [
{
"exact_snippets": "Good follow-up compliance",
"criterion": "follow-up compliance",
"requirements": [
{
"requirement_type": "quality",
"expected_value": "good"
}
]
}
]
},
{
"line": "6. Women of childbearing age (15 to 49 years old) must undergo a pregnancy test within 7 days before the start of the test and the result is negative; Fertile men and women must consent to the use of effective contraception to ensure pregnancy during the study period and within 3 months of the examination;",
"criterions": [
{
"exact_snippets": "Women of childbearing age (15 to 49 years old)",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 15,
"unit": "years"
},
{
"operator": "<=",
"value": 49,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "Women of childbearing age ... must undergo a pregnancy test within 7 days before the start of the test and the result is negative",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "within 7 days before the start of the test"
},
{
"requirement_type": "result",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "Fertile men and women must consent to the use of effective contraception",
"criterion": "use of effective contraception",
"requirements": [
{
"requirement_type": "consent",
"expected_value": true
}
]
},
{
"exact_snippets": "use of effective contraception to ensure pregnancy during the study period and within 3 months of the examination",
"criterion": "duration of contraception use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during the study period and within 3 months of the examination"
}
]
}
]
},
{
"line": "7. Subject patients can fully understand and voluntarily participate in this experiment, and sign informed consent.",
"criterions": [
{
"exact_snippets": "Subject patients can fully understand",
"criterion": "understanding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "voluntarily participate",
"criterion": "voluntary participation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "sign informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Severe abnormal liver and kidney function;",
"criterions": [
{
"exact_snippets": "Severe abnormal liver ... function",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "normality",
"expected_value": false
}
]
},
{
"exact_snippets": "Severe abnormal ... kidney function",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "normality",
"expected_value": false
}
]
}
]
},
{
"line": "2. Pregnant, pregnant and lactating women;",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "lactating women",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Can not lie flat for half an hour;",
"criterions": [
{
"exact_snippets": "Can not lie flat for half an hour",
"criterion": "ability to lie flat",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 30,
"unit": "minutes"
}
}
]
}
]
},
{
"line": "4. Unable to obtain informed consent;",
"criterions": [
{
"exact_snippets": "Unable to obtain informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "obtainability",
"expected_value": true
}
]
}
]
},
{
"line": "5. Suffering from claustrophobia or other mental illness;",
"criterions": [
{
"exact_snippets": "Suffering from claustrophobia",
"criterion": "claustrophobia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "other mental illness",
"criterion": "mental illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. People who are known to be allergic to the investigational drug or its excipients in the investigational therapy;",
"criterions": [
{
"exact_snippets": "allergic to the investigational drug",
"criterion": "allergy to investigational drug",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "allergic to ... its excipients in the investigational therapy",
"criterion": "allergy to excipients in investigational therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "7. Other conditions deemed unsuitable for participation in the trial by the investigator.",
"criterions": [
{
"exact_snippets": "Other conditions deemed unsuitable for participation in the trial by the investigator.",
"criterion": "other conditions",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": "deemed unsuitable by the investigator"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}